CNTA 250117 17.50C (CNTA250117C17500) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

CNTA250117C17500

Watchlist

1.22
0.000.00%

15min DelayTrading Dec 24 09:37 ET

0.00High0.00Low

Intraday

5D
Daily

News

Centessa Pharmaceuticals: Promising Market Position and Growth Potential in Orexin Agonists for Narcolepsy
TipRanksJan 2 20:15 ET
Centessa Pharmaceuticals Plc (NASDAQ:CNTA) Shares Could Be 30% Below Their Intrinsic Value Estimate
Yahoo FinanceJan 1 05:17 ET
Centessa Pharmaceuticals Secures Loan Facility, Repays Debt
MT NewswiresDec 31 13:22 ET
Five Reasons Why UBS Is Overweight the UK
Seeking AlphaDec 20, 2024 13:30 ET
Why Did Centessa Pharmaceuticals PLC (CNTA) Jump Yesterday?
Yahoo FinanceDec 20, 2024 10:31 ET
Centessa Pharmaceuticals Insider Sold Shares Worth $1,615,255, According to a Recent SEC Filing
MT NewswiresDec 6, 2024 17:06 ET

Comments

Stock_Drift

Sep 26, 2024 05:05

$Centessa Pharmaceuticals (CNTA.US)$

Trytosaveabit

Apr 23, 2024 15:37

Update

$Centessa Pharmaceuticals (CNTA.US)$ Press Release: Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
Dow Jones· 15 mins ago
Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
BOSTON and LONDON, April 23, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for p...

Trytosaveabit

Apr 22, 2024 06:10

Update

$Centessa Pharmaceuticals (CNTA.US)$ The FDA Has Cleared Centessa Pharmaceuticals' Investigational New Drug Application To Initiate A Phase 1 First-in-human, Clinical Trial Of ORX750 For Narcolepsy

Meltyy

Apr 2, 2024 22:13

Gear up for AACR24!

See Biotech companies with cancer assets 👇
⇨ held by 5 biopharma-focused hedge funds! 🔥
$Arcellx (ACLX.US)$ : Anito-cel (Ph 2)
$Adaptimmune Therapeutics (ADAP.US)$ : Afami-cel (PDUFA) ⏳
$Bicycle Therapeutics (BCYC.US)$ : BT8009 (Ph 1/2)
$Centessa Pharmaceuticals (CNTA.US)$ : LB101 (Ph 1/2)
$Day One Biopharmaceuticals (DAWN.US)$ : Tovorafenib (PDUFA) (check comments for details)
$Fate Therapeutics (FATE.US)$ : FT576 (Ph 1)
$Fusion Pharmaceuticals (FUSN.US)$ : FPI-2265 (Ph 2)
$GRCL: ...

JESSE JAMES8832

Feb 10, 2024 10:15

buy

$Centessa Pharmaceuticals (CNTA.US)$